A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of the 24-Hour Intragastric pH Profile After 5 Days of Once Daily Oral Administration of Either Esomeprazole 40 Mg or Pantoprazole 40 Mg Following Once Daily Infusion of Intravenous Pantoprazole 40 Mg for 5 Days in Healthy Volunteer Subjects

Trial Profile

A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of the 24-Hour Intragastric pH Profile After 5 Days of Once Daily Oral Administration of Either Esomeprazole 40 Mg or Pantoprazole 40 Mg Following Once Daily Infusion of Intravenous Pantoprazole 40 Mg for 5 Days in Healthy Volunteer Subjects

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2009

At a glance

  • Drugs Esomeprazole; Pantoprazole; Pantoprazole
  • Indications Gastro-oesophageal reflux
  • Focus Pharmacodynamics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 09 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top